1. Home
  2. TVTX vs TRN Comparison

TVTX vs TRN Comparison

Compare TVTX & TRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$42.73

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Trinity Industries Inc.

TRN

Trinity Industries Inc.

HOLD

Current Price

$34.63

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TVTX
TRN
Founded
N/A
1933
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Railroads
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
TVTX
TRN
Price
$42.73
$34.63
Analyst Decision
Buy
Hold
Analyst Count
11
1
Target Price
$35.10
$34.00
AVG Volume (30 Days)
1.4M
499.2K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
3.55%
EPS Growth
92.89
85.98
EPS
N/A
3.05
Revenue
N/A
$2,156,900,000.00
Revenue This Year
$43.88
$1.91
Revenue Next Year
$33.16
$15.61
P/E Ratio
N/A
$11.48
Revenue Growth
N/A
N/A
52 Week Low
$13.88
$22.38
52 Week High
$42.13
$35.62

Technical Indicators

Market Signals
Indicator
TVTX
TRN
Relative Strength Index (RSI) 77.59 65.48
Support Level $32.62 $27.61
Resistance Level N/A $35.46
Average True Range (ATR) 1.98 0.80
MACD 0.99 0.37
Stochastic Oscillator 100.00 88.78

Price Performance

Historical Comparison
TVTX
TRN

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

About TRN Trinity Industries Inc.

Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.

Share on Social Networks: